- Home
- PCRX vs SAFT Comparison
PCRX vs SAFT Comparison
Compare PCRX & SAFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- SAFT
- Stock Information
- Founded
- PCRX 2006
- SAFT 1979
- Country
- PCRX United States
- SAFT United States
- Employees
- PCRX N/A
- SAFT N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- SAFT Property-Casualty Insurers
- Sector
- PCRX Health Care
- SAFT Finance
- Exchange
- PCRX Nasdaq
- SAFT Nasdaq
- Market Cap
- PCRX 1.1B
- SAFT 1.1B
- IPO Year
- PCRX 2011
- SAFT N/A
- Fundamental
- Price
- PCRX $24.65
- SAFT $76.86
- Analyst Decision
- PCRX Buy
- SAFT
- Analyst Count
- PCRX 9
- SAFT 0
- Target Price
- PCRX $30.11
- SAFT N/A
- AVG Volume (30 Days)
- PCRX 1.2M
- SAFT 75.7K
- Earning Date
- PCRX 05-06-2025
- SAFT 05-07-2025
- Dividend Yield
- PCRX N/A
- SAFT 4.69%
- EPS Growth
- PCRX N/A
- SAFT 273.44
- EPS
- PCRX N/A
- SAFT 4.78
- Revenue
- PCRX $700,966,000.00
- SAFT $1,120,017,000.00
- Revenue This Year
- PCRX $9.48
- SAFT N/A
- Revenue Next Year
- PCRX $11.31
- SAFT N/A
- P/E Ratio
- PCRX N/A
- SAFT $16.08
- Revenue Growth
- PCRX 3.85
- SAFT 20.31
- 52 Week Low
- PCRX $11.16
- SAFT $70.71
- 52 Week High
- PCRX $31.67
- SAFT $90.00
- Technical
- Relative Strength Index (RSI)
- PCRX 51.22
- SAFT 48.46
- Support Level
- PCRX $24.10
- SAFT $73.77
- Resistance Level
- PCRX $25.35
- SAFT $80.02
- Average True Range (ATR)
- PCRX 1.49
- SAFT 2.71
- MACD
- PCRX 0.01
- SAFT -0.01
- Stochastic Oscillator
- PCRX 48.89
- SAFT 59.82
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About SAFT Safety Insurance Group Inc.
Safety Insurance Group Inc is a provider of private passenger automobile insurance in Massachusetts. The company also offers property and casualty insurance products, including commercial automobiles, homeowners, dwelling fire, umbrella, and business owner policies. It operates in the business segment of Property and casualty insurance operations.